优化肺活检操作:实验性低剂量、常规低剂量与标准剂量CT引导下肺活检诊断效能与安全性的对比分析
纳入2018年6月至2021年2月连续273例CT引导下经皮肺活检患者,分为标准剂量组93例、常规低剂量组85例和实验性低剂量组95例。三组技术成功率97.9%、100%、97.9%,灵敏度90.5%、88.1%、91.9%,特异度均为100%,总诊断准确率93.2%、90.5%、93.4%(P=0.59、1.0、0.65)。实验性低剂量组有效剂量1.49 mSv,显著低于标准剂量组5.42 mSv和常规低剂量组3.15 mSv(P<0.001)。
要点
- 三组诊断灵敏度、特异度及总准确率无显著差异(P=0.59、1.0、0.65)。
- 实验性低剂量组有效剂量1.49 mSv,显著低于标准剂量组5.42 mSv和常规低剂量组3.15 mSv。
- 气胸(P=0.71)和出血(P=0.59)发生率三组相似。
核心结论
- 实验性低剂量CT-PLB方案可达到与常规低剂量及标准剂量方案相当的诊断效能,同时大幅降低辐射剂量,可能作为安全有效的替代方案。
研究设计与样本
- 连续纳入2018年6月至2021年2月行CT-PLB的273例患者,分为标准剂量组93例、常规低剂量组85例和实验性低剂量组95例,主要评估技术成功率、诊断效能、辐射剂量、并发症及图像质量。
诊断标准与关键数值
- 标准剂量组灵敏度90.5%、特异度100%、总诊断准确率93.2%。
- 常规低剂量组灵敏度88.1%、特异度100%、总诊断准确率90.5%。
- 实验性低剂量组灵敏度91.9%、特异度100%、总诊断准确率93.4%。
- 三组灵敏度、特异度及总诊断准确率比较P值分别为0.59、1.0、0.65。
- 实验性低剂量组有效剂量1.49(1.0~1.97)mSv,标准剂量组5.42(3.92~6.91)mSv,常规低剂量组3.15(2.52~4.22)mSv,P<0.001。
临床应用与阅片要点
- 本研究制定了实验性低剂量CT-PLB的标准化六步操作流程。
- 作者认为实验性低剂量方案可作为CT-PLB安全有效的替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Lung cancer is a major cause of cancer-related deaths, emphasizing the importance of early diagnosis. CT-guided percutaneous lung biopsy(CT-PLB) is a valuable method for diagnosing lung lesions, but multiple scans can elevate radiation exposure. This study aims to compare diagnostic efficacy and safety across different CT-PLB protocols.
METHODS: 273 consecutive patients who underwent CT-PLB between June 2018 and February 2021 were enrolled, and were divided into standard-dose, conventional low-dose, and experimental low-dose groups. The study mainly evaluated technical success, diagnostic efficacy, radiation dose, complications, and image quality.
RESULTS: 93 patients were assigned to standard-dose group, 85 to conventional low-dose group, and 95 to experimental low-dose group. Technical success rates in these groups were 97.9%, 100%, and 97.9%, respectively. Procedure-related complications rates were similar across the groups(pneumothorax:p=0.71, hemorrhage:p=0.59). Sensitivity, specificity, and overall diagnostic accuracy were comparable among three groups(p=0.59,1.0,0.65), with respective values of 90.5%, 100%, and 93.2% in standard-dose group, 88.1%, 100%, and 90.5% in conventional low-dose group, and 91.9%, 100%, and 93.4% in experimental low-dose group. The effective dose (ED) in the experimental low-dose group was significantly lower compared to both the standard-dose and conventional low-dose CT-PLB groups[ED: 1.49(1.0∼1.97) mSv vs 5.42(3.92∼6.91) mSv vs 3.15(2.52∼4.22) mSv, p<0.001].
CONCLUSIONS: This study has developed a standardized six-step procedure for CT-PLB using experimental low-dose settings. It can achieve comparable diagnostic efficacy to conventional low-dose and standard-dose CT-PLB protocols while substantially reducing radiation exposure. These findings indicate that the experimental low-dose protocol could serve as a safe and effective alternative for CT-PLB.
引用
- Chen X, Wang G, Xue L, et al. Optimizing lung biopsy procedures:Comparative analysis of diagnostic efficacy and safety in experimental low-dose, conventional low-dose, and standard-dose CT-guided approaches. Eur J Radiol. 2024. PMID: 38295550. doi:10.1016/j.ejrad.2024.111331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。